James P. O’Callaghan

17.8k total citations · 1 hit paper
219 papers, 11.4k citations indexed

About

James P. O’Callaghan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, James P. O’Callaghan has authored 219 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cellular and Molecular Neuroscience, 63 papers in Molecular Biology and 44 papers in Neurology. Recurrent topics in James P. O’Callaghan's work include Neuroinflammation and Neurodegeneration Mechanisms (43 papers), Neuroscience and Neuropharmacology Research (43 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers). James P. O’Callaghan is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (43 papers), Neuroscience and Neuropharmacology Research (43 papers) and Fibromyalgia and Chronic Fatigue Syndrome Research (24 papers). James P. O’Callaghan collaborates with scholars based in United States, Australia and United Kingdom. James P. O’Callaghan's co-authors include Diane B. Miller, Krishnan Sriram, Stanley A. Benkovic, Kimberly A. Kelly, Michael I. Luster, John F. Reinhard, Jau‐Shyong Hong, Joanna Matheson, Meleik A. Hebert and K F Jensen and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

James P. O’Callaghan

214 papers receiving 11.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recent research on Gulf War illness and other health problems in veterans of the 1991 Gulf War: Effects of toxicant exposures during deployment

2015 321 citations James P. O’Callaghan, Kimberly Sullivan et al. profile →

Peers

Countries citing papers authored by James P. O’Callaghan

Since Specialization

Citations

This map shows the geographic impact of James P. O’Callaghan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James P. O’Callaghan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James P. O’Callaghan more than expected).

Fields of papers citing papers by James P. O’Callaghan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James P. O’Callaghan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James P. O’Callaghan. The network helps show where James P. O’Callaghan may publish in the future.

Co-authorship network of co-authors of James P. O’Callaghan

This figure shows the co-authorship network connecting the top 25 collaborators of James P. O’Callaghan. A scholar is included among the top collaborators of James P. O’Callaghan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James P. O’Callaghan. James P. O’Callaghan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of the Therapeutic Potential of Synthetic Growth Hormone-Releasing Hormone Antagonist MIA-690 as a Cognitive Modulator in a Mouse Model of Gulf War Illness 2025 ·International Journal of Molecular Sciences ·(unknown), Arumugam R. Jayakumar, (unknown), Renzhi Cai, Wei Sha, Erik A. Johnson, James P. O’Callaghan, Miklós Jászberényi, Andrew V. Schally, Nancy G. Klimas	1
2	A Projectile Concussive Impact Model Produces Neuroinflammation in Both Mild and Moderate-Severe Traumatic Brain Injury 2023 ·Brain Sciences ·Lindsay T. Michalovicz, Kimberly A. Kelly, Travis J. A. Craddock, James P. O’Callaghan	3
3	The β-adrenergic receptor blocker and anti-inflammatory drug propranolol mitigates brain cytokine expression in a long-term model of Gulf War Illness 2021 ·Life Sciences ·Lindsay T. Michalovicz, Kimberly A. Kelly, Diane B. Miller, Kimberly Sullivan, James P. O’Callaghan	10
4	Systems analysis of genetic variation in MPTP neurotoxicity in mice 2013 ·NeuroToxicology ·Byron C. Jones, Diane B. Miller, James P. O’Callaghan, Lu Lu, Erica L. Unger, (unknown), Robert W. Williams	19
5	Brain organochlorines and Lewy pathology: The Honolulu‐Asia aging study 2012 ·Movement Disorders ·G. Webster Ross, John E. Duda, Robert D. Abbott, Edo D. Pellizzari, Helen Petrovitch, Diane B. Miller, James P. O’Callaghan, Caroline M. Tanner, Joseph V. Noorigian, Kamal Masaki, Lenore J. Launer, Lon R. White	8
6	Protocolo sencillo para la extracción de ADN Genómico de tejido de oreja del Ratón y la Rata, usando la enzima bromelina 2011 ·SHILAP Revista de lepidopterología ·Nestor R. Gonzalez, (unknown), (unknown), James P. O’Callaghan	0
7	Time-dependent slowly-reversible inhibition of monoamine oxidase A by N-substituted 1,2,3,6-tetrahydropyridines 2011 ·Bioorganic & Medicinal Chemistry ·Wisut Wichitnithad, James P. O’Callaghan, Diane B. Miller, (unknown), Patrick S. Callery	14
8	Obesity and disability in the symptomatic Irish knee osteoarthritis population 2010 ·Irish Journal of Medical Science (1971 -) ·Nicola Ambrose, (unknown), James P. O’Callaghan, Paul G. O’Connell	7
9	Population Variation in Glial Fibrillary Acidic Protein Levels in Brain Ageing: Relationship to Alzheimer-Type Pathology and Dementia 2009 ·Dementia and Geriatric Cognitive Disorders ·Stephen B. Wharton, James P. O’Callaghan, George M. Savva, James A. R. Nicoll, Fiona E. Matthews, Julie E. Simpson, G. Forster, Pamela J. Shaw, Carol Brayne, Paul G. Ince	45
10	Low-Level Human Equivalent Gestational Lead Exposure Produces Supernormal Scotopic Electroretinograms, Increased Retinal Neurogenesis, and Decreased Retinal Dopamine Utilization in Rats 2008 ·Environmental Health Perspectives ·Donald A. Fox, Subbarao V. Kala, (unknown), J. E. Johnson, James P. O’Callaghan	30
11	The pharmacology of wakefulness 2006 ·Metabolism ·Diane B. Miller, James P. O’Callaghan	27
12	Aging, stress and the hippocampus 2005 ·Ageing Research Reviews ·Diane B. Miller, James P. O’Callaghan	158
13	Toxicological effects of α‐solamargine in experimental animals 2003 ·Phytotherapy Research ·(unknown), (unknown), (unknown), James P. O’Callaghan, Alfredo Usubillaga, (unknown)	29
14	Obesity exacerbates chemically induced neurodegeneration 2002 ·Neuroscience ·Krishnan Sriram, Stanley A. Benkovic, Diane B. Miller, James P. O’Callaghan	66
15	Phosphorylation of Protein Phosphatase Inhibitor-1 by Cdk5 2001 ·Journal of Biological Chemistry ·James Bibb, Akinori Nishi, James P. O’Callaghan, Jernej Ule, Martin J. Lan, Gretchen L. Snyder, Atsuko Horiuchi, Taro Saito, (unknown), Andrew J. Czernik, Angus C. Nairn, Paul Greengard	75
16	Quantitative Immunoblots of Proteins Resolved from Brain Homogenates: Underestimation of Specific Protein Concentration and of Treatment Effects 1999 ·Analytical Biochemistry ·James P. O’Callaghan, Hideki Imai, Diane B. Miller, (unknown)	28
17	Neurotoxicity of d‐Amphetamine in the C57BL/6J and CD‐1 Mouse 1996 ·Annals of the New York Academy of Sciences ·Diane B. Miller, James P. O’Callaghan	24
18	Increased glial fibrillary acidic protein (GFAP) levels in the brains of transgenic mice expressing the bovine growth hormone (bGH) gene 1995 ·Experimental Gerontology ·(unknown), A. Bartke, James P. O’Callaghan	35
19	Transient cortical astrogliosis induced by alcohol exposure during the neonatal brain growth spurt in rats 1993 ·Developmental Brain Research ·Charles R. Goodlett, (unknown), James P. O’Callaghan, Jolonda C. Mahoney, James R. West	84
20	The neurotoxicant MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) increases glial fibrillary acidic protein and decreases dopamine levels of the mouse striatum: Evidence for glial response to injury 1988 ·Neuroscience Letters ·John F. Reinhard, (unknown), James P. O’Callaghan	51

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact